Orthofix International N.V. (OFIX) Rating Lowered to Buy at BidaskClub

Orthofix International N.V. (NASDAQ:OFIX) was downgraded by stock analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a report issued on Tuesday, July 25th.

Several other research analysts also recently commented on the stock. Zacks Investment Research upgraded shares of Orthofix International N.V. from a “sell” rating to a “hold” rating in a report on Thursday, July 6th. BTIG Research began coverage on shares of Orthofix International N.V. in a report on Wednesday, June 21st. They issued a “buy” rating and a $52.00 target price on the stock. Langenberg & Company reiterated a “buy” rating and issued a $53.25 target price on shares of Orthofix International N.V. in a report on Wednesday, June 14th. Ladenburg Thalmann Financial Services began coverage on shares of Orthofix International N.V. in a report on Wednesday, June 14th. They issued a “buy” rating and a $53.25 target price on the stock. Finally, SunTrust Banks, Inc. began coverage on shares of Orthofix International N.V. in a report on Tuesday, May 23rd. They issued a “buy” rating and a $49.00 target price on the stock. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $52.75.

Shares of Orthofix International N.V. (OFIX) traded up 1.17% on Tuesday, hitting $47.50. The company had a trading volume of 87,905 shares. The company has a market cap of $863.08 million, a price-to-earnings ratio of 111.24 and a beta of 0.25. Orthofix International N.V. has a 12-month low of $32.51 and a 12-month high of $49.60. The company has a 50 day moving average of $45.66 and a 200-day moving average of $40.89.

Orthofix International N.V. (NASDAQ:OFIX) last announced its earnings results on Monday, August 7th. The medical device company reported $0.42 EPS for the quarter, topping the consensus estimate of $0.41 by $0.01. The firm had revenue of $108.90 million for the quarter, compared to the consensus estimate of $102.94 million. Orthofix International N.V. had a net margin of 1.88% and a return on equity of 9.96%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.41 EPS. On average, analysts forecast that Orthofix International N.V. will post $1.55 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This report was originally published by [[site]] and is the sole property of of [[site]]. If you are reading this report on another domain, it was illegally stolen and republished in violation of international copyright & trademark laws. The legal version of this report can be viewed at [[permalink]].

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Numeric Investors LLC increased its position in Orthofix International N.V. by 15.2% in the second quarter. Numeric Investors LLC now owns 98,100 shares of the medical device company’s stock valued at $4,560,000 after buying an additional 12,956 shares during the last quarter. Voya Investment Management LLC increased its position in Orthofix International N.V. by 10.7% in the second quarter. Voya Investment Management LLC now owns 8,622 shares of the medical device company’s stock valued at $401,000 after buying an additional 832 shares during the last quarter. OxFORD Asset Management LLP increased its position in Orthofix International N.V. by 16.5% in the second quarter. OxFORD Asset Management LLP now owns 74,739 shares of the medical device company’s stock valued at $3,474,000 after buying an additional 10,574 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Orthofix International N.V. by 11.6% in the second quarter. Dimensional Fund Advisors LP now owns 870,120 shares of the medical device company’s stock valued at $40,443,000 after buying an additional 90,349 shares during the last quarter. Finally, Parametric Portfolio Associates LLC increased its position in Orthofix International N.V. by 18.0% in the second quarter. Parametric Portfolio Associates LLC now owns 57,936 shares of the medical device company’s stock valued at $2,693,000 after buying an additional 8,831 shares during the last quarter. Institutional investors own 97.31% of the company’s stock.

Orthofix International N.V. Company Profile

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.